Growth Metrics

CorMedix (CRMD) Change in Account Payables (2016 - 2025)

CorMedix (CRMD) has disclosed Change in Account Payables for 12 consecutive years, with -$7.3 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 2033.02% to -$7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, up 230.04% year-over-year, with the annual reading at $3.3 million for FY2025, 230.04% up from the prior year.
  • Change in Account Payables hit -$7.3 million in Q4 2025 for CorMedix, down from $6.5 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $6.5 million in Q3 2025 to a low of -$7.3 million in Q4 2025.
  • Historically, Change in Account Payables has averaged $44817.1 across 4 years, with a median of $294400.5 in 2024.
  • Biggest YoY gain for Change in Account Payables was 648.76% in 2025; the steepest drop was 2033.02% in 2025.
  • Year by year, Change in Account Payables stood at $434753.0 in 2022, then crashed by 273.8% to -$755582.0 in 2023, then surged by 149.74% to $375851.0 in 2024, then crashed by 2033.02% to -$7.3 million in 2025.
  • Business Quant data shows Change in Account Payables for CRMD at -$7.3 million in Q4 2025, $6.5 million in Q3 2025, and $3.9 million in Q2 2025.